$MFST Medifirst is pleased to announce that it has launched a majority-owned subsidiary USA Pharma, Inc., a division for its CBD distribution, sales and products. Medifirst is also pleased to announce it has completed an agreement with Dr. Gupta Pharma LLC to distribute a line of premium CBD oils. Dr. Sanjay Gupta, its Chief Executive Officer, not related to Dr. Gupta of CNN, is a physician who specializes in the treatment of pain, and is the President of the American Pain Association. Dr. Gupta has created his own line of CBD products that, Medifirst believes, is superior in quality and production process to any CBD product in the industry. Today, Medifirst President Bruce J. Schoengood, stated, “We believe that the CBD products in Dr. Gupta’s product line will have great interest and demand by physicians and the medical community, in addition to producing unrivaled quality products for consumers.” The company plans to release further detail regarding this agreement within days of this announcement. https://finance.yahoo.com/news/medifirst-solu...01019.html